Merck & Co., Inc.
RAHWAY NJ · SEC CIK 0000310158
$5.26亿2026Q2 申报市值
13持仓数
99.8%前十大占比 · 第一大 35.8%
3 / 4新建仓 / 清仓
26Q126Q2
前十大持仓 占组合比例
2026Q2 买入最多 按季末市值估算
TRDA 新建仓+$1,280.47万
STRO 新建仓+$904.21万
EVAXION BIOTECH 新建仓+$376.38万
2026Q2 卖出最多 按季末市值估算
ENTRADA THERAPEU 清仓-$2,195.59万
SUTRO BIOPHARMA 清仓-$678.43万
EVAXION BIOTECH 清仓-$451.65万
CARISMA THERAPEU 清仓-$4.79万
2026Q2 持仓明细 点表头排序
导出 CSV 🔒| 代码 | 名称 | 市值 ▼ | 占比 | 股数 | 变动股数 | 变动 | 估算买卖额 | 操作 |
|---|---|---|---|---|---|---|---|---|
| PSNL | PERSONALIS INC | $1.88亿 | 35.75% | 14,044,943 | 0 | 0.0% | — | 不变 |
| MRNA | MODERNA INC | $1.62亿 | 30.71% | 2,308,190 | 0 | 0.0% | — | 不变 |
| KYMR | KYMERA THERAPEUTICS INC | $8,854.42万 | 16.82% | 772,165 | 0 | 0.0% | — | 不变 |
| AKTS | AKTIS ONCOLOGY INC | $3,071.02万 | 5.83% | 952,844 | 0 | 0.0% | — | 不变 |
| EIKN | EIKON THERAPEUTICS INC | $2,175.00万 | 4.13% | 1,666,666 | 0 | 0.0% | — | 不变 |
| TRDA | ENTRADA THERAPEUTICS INC | $1,280.47万 | 2.43% | 1,739,768 | 1,739,768 | — | $1,280.47万 | 新建仓 |
| STRO | SUTRO BIOPHARMA INC | $904.21万 | 1.72% | 272,351 | 272,351 | — | $904.21万 | 新建仓 |
| ALEC | ALECTOR INC | $712.69万 | 1.35% | 3,545,719 | 0 | 0.0% | — | 不变 |
| — | EVAXION BIOTECH A/S | $376.38万 | 0.71% | 1,214,126 | 1,214,126 | — | $376.38万 | 新建仓 |
| VRDN | VIRIDIAN THERAPEUTICS INC | $171.60万 | 0.33% | 93,414 | 0 | 0.0% | — | 不变 |
| — | XILIO THERAPEUTICS INC | $101.53万 | 0.19% | 105,982 | 0 | 0.0% | — | 不变 |
| — | TUHURA BIOSCIENCES INC | $4.55万 | 0.01% | 19,445 | 0 | 0.0% | — | 不变 |
| — | NEUPHORIA THERAPEUTICS INC | $4.38万 | 0.01% | 10,027 | 0 | 0.0% | — | 不变 |
| — | ENTRADA THERAPEUTICS INC | $0 | 0.00% | 0 | -1,739,768 | -100.0% | -$2,195.59万 | 清仓 |
| — | SUTRO BIOPHARMA INC | $0 | 0.00% | 0 | -272,351 | -100.0% | -$678.43万 | 清仓 |
| — | EVAXION BIOTECH A/S | $0 | 0.00% | 0 | -1,214,126 | -100.0% | -$451.65万 | 清仓 |
| — | CARISMA THERAPEUTICS INC | $0 | 0.00% | 0 | -1,473,240 | -100.0% | -$4.79万 | 清仓 |